Back to search results

Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)

Abroad (travel likely)RecruitingPHASE4

Conditions

Severe Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Alberta, Edmonton, Alberta, Canada

    Contact: Study coordinator (Amy May, RRT) · amy.may@ualberta.ca · 7804923741
    Contact: Study coordinator (Hannah Anstruther, RRT) · hannahanstruther@ualberta.ca · 7804923741
    Contact: Principal Investigator (Irvin Mayers, MD)
    Paige Lacy, PhD (Sub-investigator)
    Mohit Bhutani, MD (Sub-investigator)
    Adil Adatia, MD (Sub-investigator)
    Carol Chung, MD (Sub-investigator)
    Bo Zheng, MD (Sub-investigator)
    Subhabrata Moitra, PhD (Sub-investigator)

  • Sturgeon Community Hospital, St. Albert, Alberta, Canada

    Contact: Study coordinator (Amy May) · amy.may@ualberta.ca · 7804923741
    Contact: Study coordinator (Hannah Anstruther, RRT) · hannahanstruther@ualberta.ca · 7804923741
Study leads

  • Irvin Mayers, MD

    Principal Investigator

    University of Alberta

View source on ClinicalTrials.gov(opens in a new tab)